Debbie Wasserman Schultz actually said...

"Encouraging generic competition is crucial to ensuring that brand-name drugs become more affordable, but some drug companies have resorted to exploitative tactics that delay generic competition."

"Prevention of generic encroachment just means to delay generic competition."

"This program is supposed to be used to protect patient safety."

"These examples, alone, are too many, and they undermine our Nation's promise of equal justice."